Updated on 2025/05/10

写真a

 
KAMOUCHI MASAHIRO
 
Organization
Faculty of Medical Sciences Department of Basic Medicine Professor
Faculty of Medical Sciences Center for Cohort Studies(Concurrent)
Kyushu University Hospital Department of Nephrology,Hypertension,and Strokology(Concurrent)
Graduate School of Medical Sciences Department of Medicine(Concurrent)
Graduate School of Medical Sciences Department of Health Care Administration and Management(Concurrent)
Title
Professor
Contact information
メールアドレス
Tel
0926426953
Profile
We aim to clarify the association among a variety of factors in health and disease, including baseline characters, medical care, clinical outcomes and medical costs by analyzing big data in health care with mathematical and epidemiological methods. Our studies will contribute to establishment of evidence for optimal care and improvement of quality in medical care. Another goal of us is to elucidate the pathophysiology of cardiovascular diseases and develop a novel preemptive therapy by analyzing genome and proteome in a large cohort of stroke patients.
Homepage
External link

Degree

  • Ionic channels in vascular smooth muscle cells

Research Interests・Research Keywords

  • Research theme: Environmental epidemiology

    Keyword: Air pollutants

    Research period: 2014.3

  • Research theme: Research to improve quality of health care

    Keyword: Health care administration

    Research period: 2013.4

  • Research theme: Genomics and proteomics in ischemic stroke

    Keyword: SNP, genome, proteome

    Research period: 2002.11

  • Research theme: Multicenter hospital-based prospective study of acute stroke (Acute stroke cohort study; Fukuoka stroke Registry).

    Keyword: stroke, database, epidemiology

    Research period: 2002.4

Papers

  • Factors related to sex differences in long-term functional decline after acute ischemic stroke

    Irie, F; Nakamura, K; Matsuo, R; Wakisaka, Y; Ago, T; Kitazono, T; Kamouchi, M; Ishitsuka, T; Ibayashi, S; Kusuda, K; Fujii, K; Nagao, T; Okada, Y; Yasaka, M; Ooboshi, H; Irie, K; Omae, T; Toyoda, K; Nakane, H; Sugimori, H; Arakawa, S; Fukuda, K; Kitayama, J; Fujimoto, S; Arihiro, S; Kuroda, J; Fukushima, Y; Kiyohara, T

    SCIENTIFIC REPORTS   15 ( 1 )   13400   2025.4   ISSN:2045-2322

     More details

    Language:English   Publisher:Scientific Reports  

    This study evaluated the factors predisposing women to a more substantial functional decline than men in the chronic phase of stroke. Sex differences in functional worsening and improvement, defined as an increase and decrease in one or more modified Rankin Scale scores between the 3-month and each assessment point throughout 5 years after ischemic stroke were examined using data from a multicenter prospective stroke registry in Japan. Logistic regression analysis was performed to estimate the risk of unfavorable outcomes in women after adjusting for potential confounders. The interactions between sex and confounders were also assessed. Among 6848 patients who survived for 5 years poststroke, 39.3% were female. Female survivors were more likely to experience unfavorable functional outcomes throughout 5 years post-stroke than male survivors. The higher risk of functional worsening in women than men was more apparent among patients aged > 75 years and those without limb weakness (P for interaction for age 0.04 and for limb weakness 0.03). Older female patients, frequently experiencing frailty and multimorbidity, should be targeted in poststroke interventions to reduce the burden of long-term disability after stroke. Female patients without apparent motor impairment might also benefit from physical activity programs to maintain muscle strength.

    DOI: 10.1038/s41598-025-97668-y

    Web of Science

    Scopus

    PubMed

  • Data-driven prediction of prolonged air leak after video-assisted thoracoscopic surgery for lung cancer: Development and validation of machine-learning-based models using real-world data through the ePath system

    Tou, S; Matsumoto, K; Hashinokuchi, A; Kinoshita, F; Nakaguma, H; Kozuma, Y; Sugeta, R; Nohara, Y; Yamashita, T; Wakata, Y; Takenaka, T; Iwatani, K; Soejima, H; Yoshizumi, T; Nakashima, N; Kamouchi, M

    LEARNING HEALTH SYSTEMS   9 ( 2 )   e10469   2025.4   ISSN:2379-6146

     More details

    Language:English   Publisher:Learning Health Systems  

    Introduction: The reliability of data-driven predictions in real-world scenarios remains uncertain. This study aimed to develop and validate a machine-learning-based model for predicting clinical outcomes using real-world data from an electronic clinical pathway (ePath) system. Methods: All available data were collected from patients with lung cancer who underwent video-assisted thoracoscopic surgery at two independent hospitals utilizing the ePath system. The primary clinical outcome of interest was prolonged air leak (PAL), defined as drainage removal more than 2 days post-surgery. Data-driven prediction models were developed in a cohort of 314 patients from a university hospital applying sparse linear regression models (least absolute shrinkage and selection operator, ridge, and elastic net) and decision tree ensemble models (random forest and extreme gradient boosting). Model performance was then validated in a cohort of 154 patients from a tertiary hospital using the area under the receiver operating characteristic curve (AUROC) and calibration plots. Results: To mitigate bias, variables with missing data related to PAL or those with high rates of missing data were excluded from the dataset. Fivefold cross-validation indicated improved AUROCs when utilizing key variables, even post-imputation of missing data. Dichotomizing continuous variables enhanced performance, particularly when fewer variables were employed in the decision tree ensemble models. Consequently, regression models incorporating seven key variables in complete case analysis demonstrated superior discriminatory ability for both internal (AUROCs: 0.77–0.84) and external cohorts (AUROCs: 0.75–0.84). These models exhibited satisfactory calibration in both cohorts. Conclusions: The data-driven prediction model implementing the ePath system exhibited adequate performance in predicting PAL post-video-assisted thoracoscopic surgery, optimizing variables and considering population characteristics in a real-world setting.

    DOI: 10.1002/lrh2.10469

    Web of Science

    Scopus

    PubMed

  • Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies

    Kimura, K; Kamouchi, M; Matsumaru, Y; Kimura, T; Katsuro, R; Hosokawa, J; Kitazono, T

    JOURNAL OF THROMBOSIS AND THROMBOLYSIS   58 ( 4 )   547 - 555   2025.4   ISSN:0929-5305 eISSN:1573-742X

     More details

    Language:English   Publisher:Journal of Thrombosis and Thrombolysis  

    The P2Y12 receptor inhibitor prasugrel was approved for thrombotic stroke in Japan following the phase 3 clinical trials PRASTRO-I, -II, and -III. However, correlations between elevated platelet reaction unit (PRU) and ischemic event risk remain unclear. This post hoc integrated analysis of PRASTRO-I, -II, and -III assessed the relationships of PRU with efficacy and safety outcomes, and risk factors for high PRU (HPR). Patients from PRASTRO-I, -II, and -III receiving prasugrel or clopidogrel and with PRU values at 4 and 24 weeks after treatment initiation were included. The primary endpoint was PRU at 4 weeks; secondary endpoints included cumulative incidence of ischemic and bleeding events from study drug initiation to 48 weeks. Exploratory univariate and multivariate analyses were conducted to identify HPR risk factors. Of 2688 patients analyzed, 2595 and 2434 had PRU values available at 4 and 24 weeks, respectively. Mean PRU was numerically lower with prasugrel than clopidogrel at 4 weeks (151.3 vs. 195.4) and 24 weeks (143.8 vs. 188.0). CYP2C19 polymorphisms affected PRU at 4 and 24 weeks with clopidogrel but not with prasugrel. PRU at 4 weeks did not predict ischemic and bleeding event incidence up to 48 weeks. The CYP2C19 poor metabolizer phenotype was the strongest HPR risk factor. PRU values at 4 and 24 weeks were numerically lower with prasugrel and unaffected by CYP2C19 genetic polymorphisms. Further research is needed to clarify the relationship of PRU with ischemic and bleeding events.

    DOI: 10.1007/s11239-025-03093-3

    Web of Science

    Scopus

    PubMed

  • Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke A Systematic Review and Meta-Analysis

    Khan, F; Writing Comm PERSIST Collaborators; Yogendrakumar, V; Lun, RD; Ganesh, A; Barber, PA; Lioutas, VA; Vinding, NE; Algra, A; Weimar, C; Ögren, J; Edwards, JD; Swartz, RH; Ois, A; Giralt-Steinhauer, E; Khanevski, AN; Leng, XY; Tian, X; Leung, TW; Park, HK; Bae, HJ; Kamouchi, M; Ago, T; Verburgt, E; Verhoeven, J; de Leeuw, FE; Berghout, BP; Ikram, MK; Kostev, K; Whiteley, W; Uehara, T; Minematsu, K; Ildstad, F; Fandler-Höfler, S; Aarnio, K; von Sarnowski, B; Foschi, M; Jing, J; Baik, M; Kim, YD; Spampinato, MD; Hasegawa, Y; Perera, K; Purroy, F; Dutta, D; Yang, XL; Lippert, J; Myers, L; Bravata, DM; Santos, M; Coveney, S; Garcia-Esperon, C; Levi, CR; Lorenzetti, DL; Vatanpour, S; Wang, YJ; Albers, GW; Lavallee, P; Amarenco, P; Coutts, SB; Hill, MD

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION   333 ( 17 )   1508 - 1519   2025.3   ISSN:0098-7484 eISSN:1538-3598

     More details

    Language:English   Publisher:JAMA  

    IMPORTANCE After a transient ischemic attack (TIA) or minor stroke, the long-term risk of stroke is not well-known. OBJECTIVE To determine the annual incidence rates and cumulative incidences of stroke up to 10 years after TIA or minor stroke. DATA SOURCES MEDLINE, Embase, and Web of Science were searched from inception through June 26, 2024. STUDY SELECTION Prospective or retrospective cohort studies reporting stroke risk during a minimum follow-up of 1 year in patients with TIA or minor stroke. DATA EXTRACTION AND SYNTHESIS Two reviewers independently performed data extraction and assessed study quality. Unpublished aggregate-level data on number of events and person-years during discrete follow-up intervals were obtained directly from the authors of the included studies to calculate incidence rates in individual studies. Data across studies were pooled using random-effects meta-analysis. MAIN OUTCOMES AND MEASURES The primary outcome was any stroke. Study-level characteristics were investigated as potential sources of variability in stroke rates across studies. RESULTS The analysis involved 171 068 patients (median age, 69 years [IQR, 65-71]; median proportion of male patients, 57% [IQR, 52%-60%]) from 38 included studies. The pooled rate of stroke per 100 person-years was 5.94 events (95% CI, 5.18-6.76; 38 studies; I2 = 97%) in the first year, 1.80 events (95% CI, 1.58-2.04; 25 studies; I2 = 90%) annually in the second through fifth years, and 1.72 events (95% CI, 1.31-2.18; 12 studies; I2 = 84%) annually in the sixth through tenth years. The 5- and 10-year cumulative incidence of stroke was 12.5% (95% CI, 11.0%-14.1%) and 19.8% (95% CI, 16.7%-23.1%), respectively. Stroke rates were higher in studies conducted in North America (rate ratio [RR], 1.43 [95% CI, 1.36-1.50]) and Asia (RR, 1.62 [95% CI, 1.52-1.73]), compared with Europe, in cohorts recruited in or after 2007 (RR, 1.42 [95% CI, 1.23-1.64]), and in studies that used active vs passive outcome ascertainment methods (RR, 1.11 [95% CI, 1.07-1.17]). Studies focusing solely on patients with TIA (RR, 0.68 [95% CI, 0.65-0.71) or first-ever index events (RR, 0.45 [95% CI, 0.42-0.49]) had lower stroke rates than studies with an unselected patient population. CONCLUSIONS AND RELEVANCE Patients who have had a TIA or minor stroke are at a persistently high risk of subsequent stroke. Findings from this study underscore the need for improving long-term stroke prevention measures in this patient group.

    DOI: 10.1001/jama.2025.2033

    Web of Science

    Scopus

    PubMed

  • Clinical Outcomes following Acute Ischaemic Stroke in Patients with Comorbid Cancer

    Sato, N; Kiyuna, F; Wakisaka, K; Ohya, Y; Ueki, K; Yoshimura, S; Nakamura, K; Hata, J; Wakisaka, Y; Ago, T; Kamouchi, M; Kitazono, T; Matsuo, R

    CEREBROVASCULAR DISEASES   1 - 9   2025.3   ISSN:1015-9770 eISSN:1421-9786

     More details

    Language:English   Publisher:Cerebrovascular Diseases  

    Introduction: The prevalence of comorbid cancer is higher in patients with ischaemic stroke than in the general population, and recent studies have attempted to clarify the relationship between the two. We observed that the evidence for the impact of comorbid cancer on post-stroke clinical outcomes was not established and aimed to investigate it among patients with new-onset acute ischaemic stroke. Methods: We evaluated 13,345 patients with acute ischaemic stroke who were functionally independent before onset (modified Rankin Scale [mRS] score of 0–2) and admitted to one of the seven stroke centres in Fukuoka, Japan, between June 2007 and September 2019. A total of 13,047 patients were included in the analyses after excluding those with missing potential confounders (n = 13) or loss to followup (n = 298). Comorbid cancer was diagnosed based on previous history or newly identified cancer during hospitalisation for the index stroke. Multivariable-adjusted Poisson regression analyses were conducted to assess the association of comorbid cancer with post-stroke outcomes: clinically assessed poor functional outcomes (mRS score, 3–6), functional dependency (mRS score, 3–5), and mortality (mRS score, 6) at 3 months after stroke onset. Results: Of 13,047 patients (aged 71.1 ± 12.3 years, 62.8% men) with acute ischaemic stroke, 2,027 (15.6%) had comorbid cancer. Among those with no cancer, 24.0% recorded poor functional outcomes; with non-active cancer, 30.7%; and with active cancer, 46.1%. The risk ratios (95% confidence interval) for poor functional outcome at 3 months increased with active cancer (1.50 [1.37–1.65] vs. no cancer) and recently diagnosed cancer (7 months–4 years: 1.43 [1.28–1.59], ≤6 months: 1.53 [1.36–1.72]) after adjusting for potential confounders. These associations were observed for both 3-month functional dependency and mortality. No significant heterogeneity was observed in these associations across sex, nutritional status, inflammatory status, or coagulation status, except for age and stroke severity. The strongest association with 3-month poor functional outcome was observed for pancreatic cancer, followed by gallbladder and biliary tract, liver, and colon cancers. Conclusions: Comorbid cancer is likely to be independently associated with unfavourable outcomes in patients with acute ischaemic stroke.

    DOI: 10.1159/000544700

    Web of Science

    Scopus

    PubMed

▼display all

Books

  • マスター脳卒中学  脳卒中のリスクファクター 糖尿病

    松尾 龍, 鴨打正浩(Role:Joint author)

    2019.2 

     More details

    Language:Japanese   Book type:Scholarly book

  • マスター脳卒中学 脳卒中のリスクファクター 総論

    松尾 龍, 鴨打正浩(Role:Joint author)

    2019.2 

     More details

    Language:Japanese   Book type:Scholarly book

  • Health Issues and Care System for the Elderly. Stroke in the Elderly.

    Masahiro Kamouchi(Role:Joint author)

    2018.11 

     More details

    Language:English   Book type:Scholarly book

  • 最新臨床脳卒中学(下) 脳出血各論、 特殊な脳出血、腎不全患者の脳出血

    鴨打正浩(Role:Sole author)

    日本臨牀社  2014.10 

     More details

    Responsible for pages:432-437   Language:Japanese   Book type:Scholarly book

  • 最新臨床脳卒中学(上) 画像検査・診断 生化学検査 新規血液バイオマーカーの探索

    松尾 龍, 鴨打正浩(Role:Joint author)

    日本臨牀社  2014.7 

     More details

    Responsible for pages:606-610   Language:Japanese   Book type:Scholarly book

▼display all

Presentations

  • M2急性閉塞に対する脳血管内治療の有効性の検討 ―傾向スコアマッチング解析―: Fukuoka Stroke Registry

    佐原範之、松尾龍、橋本剛、清原卓也、中村晋之、入江芙美、脇坂義信、吾郷哲朗、鴨打正浩、北園孝成

    第50回日本脳卒中学会学術集会 

     More details

    Event date: 2025.3

  • 推定除脂肪量指数と脳梗塞発症後の短期予後との関連:Fukuoka Stroke Registry

    橋本剛、松尾龍、佐原範之、清原卓也、中村晋之、入江芙美、脇坂義信、吾郷哲朗、鴨打正浩、北園孝成

    第50回日本脳卒中学会学術集会 

     More details

    Event date: 2025.3

  • 脳卒中の発症・再発予防また脳卒中転帰不良抑制のための血圧管理

    脇坂義信、清原卓也、中村晋之、松尾龍、吾郷哲朗、鴨打正浩、北園孝成

    第50回日本脳卒中学会学術集会 

     More details

    Event date: 2025.3

  • 急性期脳梗塞患者の長期予後の推移:福岡脳卒中データベース研究

    松尾龍、脇坂義信、吾郷哲朗、鴨打正浩、北園孝成

    第50回日本脳卒中学会学術集会 

     More details

    Event date: 2025.3

  • NVAF合併脳梗塞におけるHELT-E2S2スコアと脳梗塞再発との関連性の検討:Fukuoka Stroke Registry

    中村晋之、松尾龍、橋本剛、佐原範之、清原卓也、脇坂義信、吾郷哲朗、鴨打正浩、北園孝成

    第50回日本脳卒中学会学術集会 

     More details

    Event date: 2025.3

▼display all

MISC

  • 心不全 脳卒中後の機能的状態との関連は十分認識されていない(Heart Failure: Under-Recognized Link to Post-Stroke Functional Status)

    Kamouchi Masahiro

    Circulation Journal   87 ( 3 )   409 - 411   2023.2   ISSN:1346-9843

     More details

    Language:English   Publisher:(一社)日本循環器学会  

  • Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Mishra A., Malik R., Hachiya T., Jürgenson T., Namba S., Posner D.C., Kamanu F.K., Koido M., Le Grand Q., Shi M., He Y., Georgakis M.K., Caro I., Krebs K., Liaw Y.C., Vaura F.C., Lin K., Winsvold B.S., Srinivasasainagendra V., Parodi L., Bae H.J., Chauhan G., Chong M.R., Tomppo L., Akinyemi R., Roshchupkin G.V., Habib N., Jee Y.H., Thomassen J.Q., Abedi V., Cárcel-Márquez J., Nygaard M., Leonard H.L., Yang C., Yonova-Doing E., Knol M.J., Lewis A.J., Judy R.L., Ago T., Amouyel P., Armstrong N.D., Bakker M.K., Bartz T.M., Bennett D.A., Bis J.C., Bordes C., Børte S., Cain A., Ridker P.M., Cho K., Chen Z., Cruchaga C., Cole J.W., de Jager P.L., de Cid R., Endres M., Ferreira L.E., Geerlings M.I., Gasca N.C., Gudnason V., Hata J., He J., Heath A.K., Ho Y.L., Havulinna A.S., Hopewell J.C., Hyacinth H.I., Inouye M., Jacob M.A., Jeon C.E., Jern C., Kamouchi M., Keene K.L., Kitazono T., Kittner S.J., Konuma T., Kumar A., Lacaze P., Launer L.J., Lee K.J., Lepik K., Li J., Li L., Manichaikul A., Markus H.S., Marston N.A., Meitinger T., Mitchell B.D., Montellano F.A., Morisaki T., Mosley T.H., Nalls M.A., Nordestgaard B.G., O’Donnell M.J., Okada Y., Onland-Moret N.C., Ovbiagele B., Peters A., Psaty B.M., Rich S.S.

    Nature   612 ( 7938 )   E7   2022.12   ISSN:00280836

     More details

    Language:English   Publisher:Nature  

    In the version of this article initially published, the name of the PRECISE4Q Consortium was misspelled as “PRECISEQ” and has now been amended in the HTML and PDF versions of the article. Further, data in the first column of Supplementary Table 55 were mistakenly shifted and have been corrected in the file accompanying the HTML version of the article.

    DOI: 10.1038/s41586-022-05492-5

    Scopus

    PubMed

  • 【脳血管障害-脳卒中医療の今,そして未来】実地医家に必要な最新の知識 脳卒中疫学の最近の話題

    松尾 龍, 鴨打 正浩

    Medical Practice   39 ( 12 )   1797 - 1803   2022.12   ISSN:0910-1551

     More details

    Language:Japanese   Publisher:(株)文光堂  

  • 脳卒中再発率はここ20年間下げ止まり傾向

    鴨打正浩

    脳卒中Experts' Eyes   2022.11

     More details

    Language:Japanese   Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

  • 特集Ⅱ/脳血管障害 <セミナー>実地医家に必要な最新の知識 1.脳卒中疫学の最近の話題

    松尾龍、鴨打正浩

    2022.11

     More details

    Language:Japanese   Publishing type:Article, review, commentary, editorial, etc. (scientific journal)  

▼display all

Professional Memberships

  • 日本神経学会

  • 日本リハビリテーション医学会

  • 日本脳ドック学会

  • 日本脳循環代謝学会

  • 日本健康支援学会

▼display all

Committee Memberships

  • 日本健康支援学会   Councilor   Domestic

    2020.4 - Present   

  • 日本脳ドック学会   Councilor   Domestic

    2016.7 - Present   

  • 日本骨髄間葉系幹細胞治療学会   世話人   Domestic

    2016.6 - Present   

  • 日本脳卒中学会   代議員   Domestic

    2011.8 - Present   

  • 日本老年医学会   代議員   Domestic

    2011.7 - Present   

▼display all

Academic Activities

  • 座長

    日本脳卒中学会学術集会  ( Japan ) 2023.3

     More details

    Type:Competition, symposium, etc. 

  • Screening of academic papers

    Role(s): Peer review

    2023

     More details

    Type:Peer review 

    Number of peer-reviewed articles in foreign language journals:18

    Number of peer-reviewed articles in Japanese journals:5

  • 日本脳ドック学会報

    2022.6 - Present

     More details

    Type:Academic society, research group, etc. 

  • Screening of academic papers

    Role(s): Peer review

    2022

     More details

    Type:Peer review 

    Number of peer-reviewed articles in foreign language journals:17

    Number of peer-reviewed articles in Japanese journals:5

    Proceedings of domestic conference Number of peer-reviewed papers:20

  • Screening of academic papers

    Role(s): Peer review

    2021

     More details

    Type:Peer review 

    Number of peer-reviewed articles in foreign language journals:22

    Number of peer-reviewed articles in Japanese journals:2

    Proceedings of domestic conference Number of peer-reviewed papers:15

▼display all

Research Projects

  • 脳卒中後QOLと効用値に基づく費用対効果分析の基盤構築

    Grant number:25H01083  2025.4 - 2029.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (A)

    鴨打 正浩

      More details

    Grant type:Scientific research funding

    CiNii Research

  • PM2.5成分の短期変動による健康影響を定量化する全国規模の環境疫学研究

    Grant number:22576054  2022 - 2024

    Grants-in-Aid for Scientific Research  環境研究総合推進費

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • Data-driven high-performance medicine for stroke

    Grant number:23K21506  2021.4 - 2025.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    鴨打 正浩, 福田 治久, 松尾 龍, 北園 孝成, 松本 晃太郎

      More details

    Grant type:Scientific research funding

    大規模脳卒中患者登録データに対して、正則化線形回帰や決定木アンサンブル学習などの機械学習手法を用いて、網羅的な変数による機能予後、生命予後の予測モデルを開発する。交差検証、時間的検証、外部検証により、予測モデルの妥当性を検証する。リスク調整を行った上で、標準偏回帰係数や変数重要度から短期及び長期機能予後、生命予後、ADL×生存年等のアウトカムの予測確率に対して大きな影響を及ぼす診療行為を抽出する。シミュレーションを行い、各診療行為の変数の実測値と仮想値における推定予後確率の変化を検討する。診療点数あたりの効果に変換し費用対効果を推定する。

    CiNii Research

  • 脳卒中患者における医療の質の妥当性の検討とデータベース構築に関する研究

    Grant number:21K10330  2021.4 - 2024.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    松尾 龍, 北園 孝成, 鴨打 正浩

      More details

    Grant type:Scientific research funding

    効果的、効率的な医療提供体制の確立には、医療の質の指標としてQIの妥当性を評価するとともに、持続的に医療の変化とともに変わるQIを評価しなければならない。本研究では、(1)本邦におけるQIについて、機能転帰を考慮したアウトカム評価で妥当性を検証する、(2)継続的にデータを収集し常に医療の質を評価できるデータベースを構築する、を行うことにより、効果的、効率的な脳卒中医療提供と脳卒中患者のアウトカムの改善の実現が期待できる。

    CiNii Research

  • 脳卒中疾病負荷軽減のためのデータ駆動型最適化医療の構築

    Grant number:21H03165  2021 - 2024

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

▼display all

Class subject

  • 老年病学

    2024.10 - 2025.3   Second semester

  • 臨床医学II-②

    2024.4 - 2024.9   First semester

  • 地域包括ケアシステム

    2024.4 - 2024.9   First semester

  • 健康行動科学

    2024.4 - 2024.9   First semester

  • 生命の科学A

    2023.4 - 2023.9   First semester

▼display all

Social Activities

  • 大牟田市健康福祉推進会議

    2019

     More details

    大牟田市健康福祉推進会議

  • 公開講座「環境因子と脳梗塞 大気汚染と脳梗塞の知られざる関係」

    九州大学大学院医学系学府 医療経営・管理学専攻  福岡  2018.12

     More details

    Audience:General, Scientific, Company, Civic organization, Governmental agency

    Type:Lecture

  • 春日市高齢者福祉計画・介護保険事業計画検討協議会

    2017

     More details

    春日市高齢者福祉計画・介護保険事業計画検討協議会

  • 春日市介護保険運営協議会

    2015

     More details

    春日市介護保険運営協議会

  • 大牟田市健康づくり推進会議

    2014

     More details

    大牟田市健康づくり推進会議

▼display all

Media Coverage

  • とっても健康ランド「危ない頭痛」 TV or radio program

    KBCテレビ  2015.10

     More details

    とっても健康ランド「危ない頭痛」

  • 大気汚染物質“健康への影響は” TV or radio program

    RKBテレビ  2014.5

     More details

    大気汚染物質“健康への影響は”

  • とっても健康ランド 「脳こうそく」 TV or radio program

    KBCテレビ  2012.1

     More details

    とっても健康ランド 「脳こうそく」

  • とっても健康ランド 「脳梗塞」 TV or radio program

    KBCテレビ  2010.9

     More details

    とっても健康ランド 「脳梗塞」

  • 脳卒中シンポジウム Newspaper, magazine

    佐賀新聞  2004.6

     More details

    脳卒中シンポジウム

Activities contributing to policy formation, academic promotion, etc.

  • 2019.11 - Present   公益財団法人 日本医療機能評価機構

    医療の質向上のための体制整備事業 QI 標準化部会

Travel Abroad

  • 1996.4 - 1999.9

    Staying countory name 1:Belgium   Staying institution name 1:Leuven大学

Specialized clinical area

  • Biology / Medicine, Dentistry and Pharmacy / Clinical Internal Medicine / Stroke Science

  • Biology / Medicine, Dentistry and Pharmacy / Social Medicine / Public Health/Health Science

  • Other

    医療経営・管理学

Clinician qualification

  • Specialist

    The Japan Stroke Society

  • Preceptor

    The Japan Stroke Society

  • Specialist

    The Japan Geriatrics Society

  • Preceptor

    The Japan Geriatrics Society

  • Certifying physician

    The Japanese Society of Internal Medicine(JSIM)

▼display all

Year of medical license acquisition

  • 1987